MAAT PHARMA – Trademark Portfolio
Entity Type: 99
MAAT PHARMA holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 8 trademarks are registered and 1 is pending. Notable registered marks include M, MAÂT, BUTYCORE, SIFTAXYS, and XERVYTEG.
70 avenue Tony Garnier
F-69007 LYON
Showing of trademarks Trademarks
Trademark Classifications
MAAT PHARMA's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does MAAT PHARMA have?
MAAT PHARMA has 12 U.S. trademarks filed with the USPTO. Of these, 8 registered, 1 pending, 1 abandoned.
What trademark classes does MAAT PHARMA file in?
MAAT PHARMA files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MAAT PHARMA's most well-known trademarks?
MAAT PHARMA's registered trademark portfolio includes well-known marks such as M, MAÂT, BUTYCORE, SIFTAXYS, and XERVYTEG. These are among 8 currently registered trademarks in the portfolio.
What is MAAT PHARMA's trademark registration success rate?
MAAT PHARMA has a 89% trademark registration rate, with 8 out of 9 resolved applications resulting in successful registration. Currently, 1 application is pending review.